Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1367950 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Abstract
A novel isoquinuclidine containing selective melanocortin subtype-4 receptor small molecule agonist, 3 (RY764), is reported. Its in vivo characterization revealed mechanism-based food intake reduction and erectile activity augmentation in rodents.
Graphical abstractA novel isoquinuclidine containing selective melanocortin subtype-4 receptor small molecule agonist, 3 (RY764), is reported. Its in vivo characterization revealed mechanism-based food intake reduction and erectile activity augmentation in rodents.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Zhixiong Ye, Liangqin Guo, Khaled J. Barakat, Patrick G. Pollard, Brenda L. Palucki, Iyassu K. Sebhat, Raman K. Bakshi, Rui Tang, Rubana N. Kalyani, Aurawan Vongs, Airu S. Chen, Howard Y. Chen, Charles I. Rosenblum, Tanya MacNeil, David H. Weinberg,